Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CANDLE

Financiado

Cerrado

Cancer Diagnosis by Multiplex Protein Epitope Profiling

Cancer incidence is continuously increasing, making it a major concern of European governments. Cheaper, more sensitive and specific diagnostic tests are needed to foster early cancer diagnosis, thereby alleviating the impact of c... ver más

31/10/2015

BioSystems Kft.

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BIOSYSTEMS INTERNATIONAL KUTATO FEJLESZTO HAS... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-10-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

BioSystems Kft.

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CANOMICS Multicentre discovery of breast cancer biomarkers 86K€ Cerrado

PLEC2021-007892 Plataforma (Oncodeeplasm) para inmunoensayos optoplasmónicos... 336K€ Cerrado

PROTBIOFLUID PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN P... 355K€ Cerrado

DeteCTCs The first multi cancer liquid biopsy test for detection of e... 3M€ Cerrado

CTQ2015-64402-C2-2-R NUEVAS PLATAFORMAS DE MULTIPLEXADO ELECTROANALITICAS PARA LA... 105K€ Cerrado

MAINTRAC-Auto MAINTRAC Auto Automatization and validation of a liquid bio... 71K€ Cerrado

Duración del proyecto: 2 meses Fecha Inicio: 2015-08-26
Fecha Fin: 2015-10-31

Líder del proyecto

BIOSYSTEMS INTERNATIONAL KUTATO FEJLESZTO HAS... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer incidence is continuously increasing, making it a major concern of European governments. Cheaper, more sensitive and specific diagnostic tests are needed to foster early cancer diagnosis, thereby alleviating the impact of cancer on citizens’ lives and reducing overall cancer care costs. BioSystems International Kft. (BSI) developed a diagnostics technology based on plasma protein epitome biomarker panels, with promising results to meet these needs for several cancers. BSI novel biomarkers-based in vitro diagnostics will bring better health outcomes for the patient as earlier detection will increase survival and will reduce overall care costs diagnosis contributing to the sustainability of the health care system. The CANDLE project objective is to consolidate the business plan and to complete clinical validation of the biomarker panels for breast and colon cancers, together representing 26.8 % of all cancer incidences in the EU. Clinically validated results obtained in CANDLE will enable BSI to seize the business opportunity and to maximize return on investments through higher royalties. BSI will license its cancer diagnostics intellectual property (IP) to fully integrated diagnostics companies who will get a competitive advantage by putting more cost-effective diagnostic products on the market. BSI already licensed its candidate diagnostic for lung cancer to a major European diagnostics company, demonstrating proof-of-concept for this business model. CANDLE will enable BSI to licence its IP after clinical validation at much better terms than for lung cancer, licensed at an earlier qualification stage. The global diagnostics market for cancers was estimated at 30 billion Euros in 2012. BSI’s IP-based diagnostics are expected to seize 4 % of this market within 10 years, resulting in more than 49.2 M€ of license revenues for BSI. CANDLE will boost BSI’s competitiveness and profitability, enabling the company to grow and to increase its innovation activity.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores